[Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2].
Intérêt de la radiothérapie stéréotaxique pour les tumeurs primitives du poumon localisées de stade T1-T2.
Cancer du poumon
Early stage
Lung cancer
Radiothérapie stéréotaxique
Stade localisé
Stereotactic body radiotherapy
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
23
06
2022
revised:
06
07
2022
accepted:
07
07
2022
pubmed:
9
9
2022
medline:
21
9
2022
entrez:
8
9
2022
Statut:
ppublish
Résumé
The historical treatment for stage I non-small cell lung cancer is surgical. Parenchymal amputation is not always possible due to cardiopulmonary comorbidities and stereotactic radiotherapy is one of the alternatives to an invasive procedure. The excellent results observed for inoperable tumors raised the question of this treatment in operable patients. This article presents the data in these two situations and the future perspectives.
Identifiants
pubmed: 36075829
pii: S1278-3218(22)00157-3
doi: 10.1016/j.canrad.2022.07.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
755-759Informations de copyright
Copyright © 2022. Published by Elsevier Masson SAS.